Skip to main content
  • Home
  • Scheme Overview

TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 28-12-2015
Asset Class: Equity
Benchmark: Nifty Pharma TRI
Expense Ratio: 2.69% As on (31-05-2017)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 73.06 Cr As on (31-05-2017)
Turn over: 0.70
NAV (₹): 25.2217
₹ 0.42 ( 1.6589%)
as on 13-05-2024
CAGR Since Inception - 11.63%
Nifty Pharma TRI - 14.42%

Fund Managers

Mr. Rupesh Patel,Mr. Sonam Udasi


Investment Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

PERFORMANCE of TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option

Scheme Performance (%) Data as on - 13-05-2024

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option 52.0 15.19 23.78 - 11.63
Nifty Pharma TRI 52.87 11.28 18.17 9.9 14.42
Equity: Sectoral-Pharma and Healthcare 49.8 13.77 24.0 15.43 18.05

RETURNS CALCULATOR for TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Key Performance and Risk Statistics of TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION

Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
Tata India Pharma & Healthcare Reg IDCW Reinv 28-12-2015 52.0 26.92 15.19 23.78 0.0
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum 25-07-2018 55.0 29.64 15.69 25.9 0.0
ABSL Pharma and Healthcare Reg Gr 05-07-2019 52.88 25.59 13.13 0.0 0.0
Tata India Pharma & Healthcare Reg Gr 28-12-2015 52.0 26.92 15.19 23.78 0.0
Nippon India Pharma Fund Gr Gr 01-06-2004 51.07 26.64 14.04 24.63 17.08
SBI HEALTHCARE Opportunities Reg Gr 14-07-1999 50.51 30.09 15.22 23.78 15.38
UTI Healthcare Reg Gr 05-08-2005 49.57 24.5 12.17 22.55 13.83
Mirae Asset Healthcare Reg Gr 10-07-2018 48.28 23.52 13.63 25.33 0.0
DSP Healthcare Reg Gr 05-11-2018 48.09 28.28 15.5 26.33 0.0
LIC MF Healthcare Fund Reg Gr 22-02-2019 46.2 20.29 9.32 19.68 0.0

Asset Allocation (%)

PORTFOLIO ANALYSIS of TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option

Portfolio as on

Top 10 Sectors in portfolio (%)

Top 10 Stocks in portfolio (%)

AMC partners we work with